{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:03:59Z","timestamp":1791241439945,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jhep.2016.11.012","type":"journal-article","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T09:30:57Z","timestamp":1480066257000},"page":"521-527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Efficacy and tolerability of an IFN-free regimen with DCV\/ASV for elderly patients infected with HCV genotype 1B"],"prefix":"10.1016","volume":"66","author":[{"given":"Hidenori","family":"Toyoda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2211-495X","authenticated-orcid":false,"given":"Takashi","family":"Kumada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritomo","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Takaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Senoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiko","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Tachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Hiraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihide","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Okanoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2016.11.012_b0005","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cgh.2009.11.018","article-title":"A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus","volume":"8","author":"Singal","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2016.11.012_b0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/hep.20984","article-title":"Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C","volume":"43","author":"Iwasaki","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.11.012_b0015","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/j.1572-0241.2007.01201.x","article-title":"The effect of age on response to therapy with peginterferon alpha plus ribavirin in a cohort of patients with chronic HCV hepatitis including subjects older than 65 yr","volume":"102","author":"Antonucci","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2016.11.012_b0020","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1478-3231.2009.02064.x","article-title":"Efficacy of peginterferon-\u03b1-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis C","volume":"30","author":"Honda","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2016.11.012_b0025","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.23691","article-title":"Effect of aging on risk of hepatocellular carcinoma in chronic hepatitis C virus infection","volume":"52","author":"Asahina","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.11.012_b0030","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/jgh.12057","article-title":"Characteristics of elderly hepatitis C virus-associated hepatocellular carcinoma patients","volume":"28","author":"Kumada","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2016.11.012_b0035","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1017\/S0950268814000478","article-title":"Changes in hepatitis C virus genotype distribution in Japan","volume":"142","author":"Toyoda","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jhep.2016.11.012_b0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1128\/JCM.35.1.201-207.1997","article-title":"New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a","volume":"35","author":"Ohno","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jhep.2016.11.012_b0045","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/hep.27113","article-title":"Daclatasvir plus asunaprevir for chronic HCV genotype 1 infection","volume":"59","author":"Kumada","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.11.012_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112647","article-title":"A novel simple assay system to quantify the percent HCV RNA levels of NS5A Y93H mutant strains and Y93 wild-type strains relative to the total HCV-RNA levels to determine the indication for antiviral therapy with NS5A inhibitors","volume":"9","author":"Uchida","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2016.11.012_b0055","unstructured":"The 21th life table of Japan (2010). Ministry of Health, Labour and Welfare. http:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/life\/21th\/index.\/html."},{"key":"10.1016\/j.jhep.2016.11.012_b0060","series-title":"Life expectancy and mortality","first-page":"43","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.jhep.2016.11.012_b0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and FibroTest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.11.012_b0070","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jhep.2016.11.012_b0075","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.27950","article-title":"Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus","volume":"62","author":"AASLD\/IDSA HCV Guidance Panel","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.11.012_b0080","first-page":"S23","article-title":"Integrated safety and tolerability of DCV + ASV in patients with chronic HCV genotype 1b infection","volume":"10","author":"Wei","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2016.11.012_b0085","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.27064","article-title":"Postinterferon \u03b1-fetoprotein elevation and risk of hepatocellular carcinoma development after sustained virological response: cause or results?","volume":"60","author":"Toyoda","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.11.012_b0090","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jhep.2016.06.009","article-title":"Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with SVR following IFN-free DAA treatment","volume":"65","author":"Kozbial","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.11.012_b0095","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2016.06.015","article-title":"Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct acting antivirals","volume":"65","author":"Conti","year":"2016","journal-title":"J Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827816306869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827816306869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T14:08:05Z","timestamp":1601215685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827816306869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0168827816306869"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2016.11.012","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and tolerability of an IFN-free regimen with DCV\/ASV for elderly patients infected with HCV genotype 1B","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2016.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}